RSV jab for infants with heart or lung disease

Infants born with types of heart or lung disease should be immunised against respiratory syncytial virus (RSV), a government advisory committee has recommended.

The Joint Committee on Vaccination and Immunisation (JCVI) said pre-term infants with Chronic Lung Disease (CLD) or Congenital Heart Disease (CHD) should be immunised using monoclonal RSV immunoglobulin palivizumab. It said there was evidence the prophylaxis was safe and cost effective in certain groups of infants.

RSV causes respiratory tract infection and can lead to bronchitis. Children born with CLD are at increased risk of contracting, and suffering complications from, the condition. RSV infection is seasonal in the UK and occurs between October and March each year.

The JCVI published a table showing when immunisation was recommended based on gestational age at birth and chronological age from birth. In this context, children are classed as having CLD if they have oxygen dependency for at least 28 days from birth.

Clinicians should also consider immunisation with Palivizumab in young children who have severe combined immunodeficiency syndrome, until immune reconstituted; and young Long Term Ventilated children.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led vaccination sites have delivered nearly three quarters of COVID-19 vaccine...

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

GPs should ignore calls to throw away usable COVID-19 vaccine, says RCGP

Suggestions that vaccination sites should throw away usable doses of COVID-19 vaccine...

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs urged to use influence to dispel COVID-19 vaccine myths and boost BAME uptake

GPs have been encouraged to use their ‘huge influence’ to bust misinformation around...

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 over-80s vaccinated against COVID-19 as figures expose regional variation

Six in 10 people aged over 80 in England received a first dose of COVID-19 vaccine...

Summary of changes to the GP contract 2021/22

Summary of changes to the GP contract 2021/22

The BMA and NHS England have agreed minor changes to the GP contract for 2021/22....